New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Neuphoria Therapeutics Inc. (NEUP) vs Quantum Biopharma Ltd. (QNTM)

Neuphoria Therapeutics Inc. and Quantum Biopharma Ltd. are both Biotechnology companies. Neuphoria Therapeutics Inc. and Quantum Biopharma Ltd. are of similar size ($12.6M and $12.6M). Across the 12 metrics below, Neuphoria Therapeutics Inc. leads on 7 and Quantum Biopharma Ltd. on 5.

Valuation

Metric NEUP QNTM Biotechnology median
P/E n/m n/m 8.49
P/S 0.81 44.07 8.56
P/B 0.54 1.05 2.04
Price to free cash flow n/m n/m 23.84
EV/EBITDA 0.45 0.21 0.69
EV/Sales (0.38) (9.50) 8.00
Earnings yield (38.02%) (335.89%) (35.81%)
Free cash flow yield (76.18%) (104.08%) (25.41%)

Profitability

Metric NEUP QNTM Biotechnology median
Gross margin — (1,068.29%) 70.18%
Operating margin — (9,699.83%) 0.00%
Net margin — (16,880.72%) 0.00%
Free cash flow margin — (6,089.39%) 0.00%
Return on equity (27.63%) (233.09%) (51.58%)
Return on assets (18.26%) (127.92%) (45.91%)
Return on invested capital (186.04%) 0.00% 0.00%

Growth

Metric NEUP QNTM Biotechnology median
Revenue growth (TTM) — — 7.20%
EPS growth (last fiscal year) (1,230.43%) 37.50% 29.04%
Revenue growth, 5-year CAGR — — 9.54%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric NEUP QNTM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 18.05 1.72 4.79
Net debt to EBITDA 1.26 0.31 1.01

Dividend

Metric NEUP QNTM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NEUP QNTM Biotechnology median
Market cap 12.55m 12.62m 150.57m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack